Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Dow
US Army
Harvard Business School
UBS
Colorcon
US Department of Justice
Citi
Covington

Generated: May 24, 2018

DrugPatentWatch Database Preview

MAXIBOLIN Drug Profile

or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Maxibolin, and what generic alternatives are available?

Maxibolin is a drug marketed by Organon Usa Inc and is included in two NDAs.

The generic ingredient in MAXIBOLIN is ethylestrenol. Additional details are available on the ethylestrenol profile page.
Summary for MAXIBOLIN
Drug patent expirations by year for MAXIBOLIN
Medical Subject Heading (MeSH) Categories for MAXIBOLIN
Synonyms for MAXIBOLIN
(17-alpha)-19-Norpregn-4-en-17-ol
(17alpha)-19-norpregn-4-en-17-ol
(17beta)-17-ethylestr-4-en-17-ol
(1S,2R,10R,11S,14S,15S)-14-ETHYL-15-METHYLTETRACYCLO[8.7.0.0(2),?.0(1)(1),(1)?]HEPTADEC-6-EN-14-OL
(8R,9S,10R,13S,14S,17S)-17-ethyl-13-methyl-2,3,6,7,8,9,10,11,12,14,15,16-dodecahydro-1H-cyclopenta[a]phenanthren-17-ol
17alpha-Ethyl-17beta-hydroxy-4-estrene
17alpha-Ethylestr-4-en-17beta-ol
17beta-Hydroxy-17alpha-ethyl-19-nor-4-androstene
19-Nor-17-alpha-pregn-4-en-17-ol
19-Nor-17alpha-pregn-4-en-17-ol
19-Nor-17alpha-pregn-4-en-17-ol (8CI)
19-Nor-17alpha-pregn-4-en-17beta-ol
19-Norpregn-4-en-17-ol, (17-alpha)-
19-Norpregn-4-en-17-ol, (17-alpha)- (9CI)
19-Norpregn-4-en-17-ol, (17alpha)-
965-90-2
AC1L22FG
ADC79EK5Q8
Ambap965-90-2
API0002632
CAS-965-90-2
CCG-101014
CHEBI:31578
CHEMBL1200623
D01414
D0SC8F
DB01493
DSSTox_CID_3024
DSSTox_GSID_23024
DSSTox_RID_76835
DTXSID6023024
Durabolin-O
Duraboral
EINECS 213-523-6
Estr-4-en-17beta-ol, 17-ethyl-
estrenolethyl
ethylestrenol
Ethylestrenol (USAN/INN)
Ethylestrenol [USAN:INN:BAN]
Ethylestrenol [USAN:INN]
Ethylestrenolum
Ethylestrenolum [INN-Latin]
Ethylnandrol
Ethylnandrol (JAN)
Ethyloestrenol
Ethyloestrenolum
Etilestrenol
Etilestrenol [INN-Spanish]
Etilestrenolo
Etilestrenolo [DCIT]
GTPL6948
HMS2051P08
HSDB 3327
LS-97392
Maxibalin
MLS000759411
MLS001424123
NC00264
NCGC00167514-01
NCGC00167514-02
Neodurabolin
NSC 37726
Orabolin
Orabolin (TN)
ORG-483
Orgabolin
Orgaboral
PL002187
SCHEMBL147908
SMR000238204
Tox21_112512
Tox21_112512_1
UNII-ADC79EK5Q8
ZINC4215863

US Patents and Regulatory Information for MAXIBOLIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Organon Usa Inc MAXIBOLIN ethylestrenol ELIXIR;ORAL 014006-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Organon Usa Inc MAXIBOLIN ethylestrenol TABLET;ORAL 014005-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

or, see our see our flat-rate plans

or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Covington
Accenture
Merck
Daiichi Sankyo
Cantor Fitzgerald
McKesson
Boehringer Ingelheim
Cipla
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.